[go: up one dir, main page]

AR066410A1 - Nuevas asparraginasas y sus usos - Google Patents

Nuevas asparraginasas y sus usos

Info

Publication number
AR066410A1
AR066410A1 ARP080101640A ARP080101640A AR066410A1 AR 066410 A1 AR066410 A1 AR 066410A1 AR P080101640 A ARP080101640 A AR P080101640A AR P080101640 A ARP080101640 A AR P080101640A AR 066410 A1 AR066410 A1 AR 066410A1
Authority
AR
Argentina
Prior art keywords
asparaginase
new
asparraginases
seq
variants
Prior art date
Application number
ARP080101640A
Other languages
English (en)
Inventor
Der Laan Jan Metske Van
Mark Cristiaan Stor
Lange Ilse De
Lisette Mohrmann
Original Assignee
Dsm Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Nv filed Critical Dsm Nv
Publication of AR066410A1 publication Critical patent/AR066410A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01001—Asparaginase (3.5.1.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Asparraginasa que tiene una amplitud de perfil de pH para la actividad de al menos 3.5. Además, la presente se relaciona con polipéptidos de asparraginasa identificados recientemente de acuerdo con cualquiera de SEQ ID N°: 2 o SEQ ID N°:4, con variantes de éstos, y con secuencias de polinucleotidos que codifican estas nuevas variantes de asparraginasa. Además, la presente se relaciona con el uso de estas nuevas variantes de asparraginasa en procesos industriales, del campo de la alimentacion y farmacéutico.
ARP080101640A 2007-04-20 2008-04-18 Nuevas asparraginasas y sus usos AR066410A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07106662 2007-04-20
EP07106660 2007-04-20
EP07106664 2007-04-20

Publications (1)

Publication Number Publication Date
AR066410A1 true AR066410A1 (es) 2009-08-19

Family

ID=39650693

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080101640A AR066410A1 (es) 2007-04-20 2008-04-18 Nuevas asparraginasas y sus usos

Country Status (14)

Country Link
US (3) US20100136169A1 (es)
EP (1) EP2137306B1 (es)
JP (1) JP2010524448A (es)
AR (1) AR066410A1 (es)
AU (1) AU2008240797A1 (es)
BR (1) BRPI0810481B1 (es)
CA (1) CA2682677A1 (es)
CL (2) CL2008001129A1 (es)
DK (1) DK2137306T3 (es)
EA (1) EA017305B1 (es)
ES (1) ES2550362T3 (es)
IL (1) IL201018A0 (es)
MX (1) MX2009011256A (es)
WO (1) WO2008128975A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730832B1 (en) 2001-09-10 2004-05-04 Luis Mayan Dominguez High threonine producing lines of Nicotiana tobacum and methods for producing
EP2851424B1 (en) 2007-03-09 2016-09-21 Novozymes A/S Thermostable asparaginases
AU2008240796A1 (en) * 2007-04-20 2008-10-30 Dsm Ip Assets B.V. Asparaginase enzyme variants and uses thereof
US20110129569A1 (en) 2009-11-26 2011-06-02 Dsm Ip Assets B.V. Method to produce fried vegetable products
CN102869772A (zh) * 2010-04-27 2013-01-09 帝斯曼知识产权资产管理有限公司 新颖的天冬酰胺酶
PL2593473T3 (pl) * 2010-07-14 2016-11-30 Asparaginaza z podstawczaków
CN103797125B (zh) 2010-11-19 2016-12-07 诺维信北美公司 用于在氨基酸氧化酶、精氨酸酶和/或天冬酰胺酶的存在下产生发酵产物的方法
WO2012158320A1 (en) * 2011-05-13 2012-11-22 Baker Hughes Incorporated Method of using asparaginase as a polyacrylamide enzyme breaker
BR112014006735B1 (pt) * 2011-09-21 2021-06-22 Reynolds Technologies, Inc Método de produção de uma planta de tabaco modificada e produto de tabaco
US8716571B2 (en) 2011-09-21 2014-05-06 Reynolds Technologies, Inc. Tobacco having reduced amounts of amino acids and methods for producing such lines
US9137958B2 (en) 2012-02-08 2015-09-22 Reynolds Technologies, Inc. Tobacco having altered amounts of environmental contaminants
EP2884857B9 (en) * 2012-08-17 2017-04-05 Novozymes A/S Method for producing a food product
CN104540394A (zh) * 2012-08-17 2015-04-22 诺维信公司 热稳定天冬酰胺酶变体以及对其进行编码的多核苷酸
SG10201804237VA (en) 2013-11-21 2018-06-28 Entegris Inc Surface coating for chamber components used in plasma systems
EP3197291A1 (en) 2014-07-04 2017-08-02 West Systems S.r.l Method and composition to reduce the formation of acrylamide in fresh or pre-fried foods to be subjected to heat treatment
HK1255069A1 (zh) * 2015-07-07 2019-08-02 Renaissance Bioscience Corp. 通过适应性进化开发减少天冬酰胺的酵母的开发及所述酵母降低丙烯酰胺形成的用途
EP3700921A4 (en) 2017-10-27 2021-12-15 Pfenex Inc. RECOMBINATION ERWINIA ASPARAGINASE PRODUCTION PROCESS
AU2018354068C1 (en) 2017-10-27 2023-03-23 Pelican Technology Holdings, Inc. Method for production of recombinant E. coli asparaginase
US20210299233A1 (en) 2018-07-12 2021-09-30 The Children's Medical Center Corporation Method for treating cancer
US20220313798A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
EP4525615A2 (en) 2022-05-14 2025-03-26 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3819540B2 (ja) * 1996-06-07 2006-09-13 株式会社林原生物化学研究所 Ｌ−アスパラギナーゼ活性を有する哺乳類由来のポリペプチド
US7037540B2 (en) 2002-09-19 2006-05-02 Frito-Lay North America, Inc. Method for reducing acrylamide formation in thermally processed foods
US7524519B2 (en) 2002-09-20 2009-04-28 The Procter & Gamble Company Method for reducing acrylamide in foods, foods having reduced levels of acrylamide, and article of commerce
DK1886582T3 (en) 2002-10-11 2015-04-20 Novozymes As Process for preparing a heat treated product
US20040101607A1 (en) 2002-11-22 2004-05-27 The Procter & Gamble Company Method for reducing acrylamide in foods, foods having reduced levels of acrylamide, and article of commerce
PL377490A1 (pl) 2002-12-19 2006-02-06 Dsm Ip Assets B.V. Nowy sposób wytwarzania żywności

Also Published As

Publication number Publication date
CL2008001129A1 (es) 2008-06-13
CL2008001128A1 (es) 2008-06-13
EP2137306A1 (en) 2009-12-30
EA200901432A1 (ru) 2010-04-30
BRPI0810481B1 (pt) 2022-05-17
IL201018A0 (en) 2011-08-01
US8323948B2 (en) 2012-12-04
BRPI0810481A2 (pt) 2014-10-07
US20100136169A1 (en) 2010-06-03
AU2008240797A1 (en) 2008-10-30
DK2137306T3 (en) 2015-10-26
EA017305B1 (ru) 2012-11-30
US20120045549A1 (en) 2012-02-23
WO2008128975A1 (en) 2008-10-30
MX2009011256A (es) 2009-11-05
US20130023029A1 (en) 2013-01-24
EP2137306B1 (en) 2015-07-29
JP2010524448A (ja) 2010-07-22
CA2682677A1 (en) 2008-10-30
ES2550362T3 (es) 2015-11-06

Similar Documents

Publication Publication Date Title
AR066410A1 (es) Nuevas asparraginasas y sus usos
EA200901430A1 (ru) Варианты фермента аспарагиназы и их применение
UA117218C2 (uk) Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
UY32607A (es) Mutantes de fgf21 y usos del mismo
CL2012001405A1 (es) Compuestos derivados de espiroindolinona-pirrolidinas; proceso de obtención; composicion farmaceutica; y uso en el tratamiento o profilaxis del cancer.
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
CO6680702A2 (es) Péptido o complejo péptido que se une a integrina alfa 2 y metodos y sus usos que implican a los mismos
GT201300131A (es) Metodos de tratamiento de trastornos asociados con el fgf21
ECSP11011450A (es) ANTICUERPOS ANTI-TNF-a Y SUS USOS
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
BR112017014060A2 (pt) composições de bacillus licheniformis rti184 e métodos de uso para beneficiar o crescimento de plantas
MX355294B (es) Artículos para el cuidado personal que tienen composiciones para el cuidado personal que tienen múltiples zonas amoldables.
CL2013003372A1 (es) Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
CL2007001488A1 (es) Anticuerpo humano o humanizado anti-integrina alfa5beta1; acido nucleico que lo codifica; vector y celula huesped que lo comprenden; procedimiento de produccion; composicion farmaceutica que lo comprende; y su uso para prevenir o tratar trastornos asociados con la integrina.
CL2013002125A1 (es) Compuestos derivados de imidazo[5,1-f][1,2,4]triazinas; composicion farmaceutica; y uso en el tratamiento del deterioro cognitivo asociado con esquizofrenia.
AR083448A1 (es) Polipeptidos con actividad quinasa
CR20150196A (es) Moléculas de unión il-17a novedosas y usos médicos de las mismas
BR112014024220A2 (pt) genes que codificam celulase
MX2016000794A (es) Composiciones farmaceuticas de pancreatina de potencia alta.
AR102950A1 (es) Variantes de lipasa y polinucleótidos que las codifican
MX2015007712A (es) Polipeptidos del factor vii de accion corta.
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
CL2011000678A1 (es) Uso de una composicion combinada de ibuprofeno y paracetamol para preparar un medicamento para el tratamiento de osteoartritis o artritis reumatoidea.

Legal Events

Date Code Title Description
FB Suspension of granting procedure